This website contains information about the WOMEN&More study into a contraceptive. The study already received approval of the METC, but is not open yet!
This research is about a contraceptive that is:
Weekly: one tablet once a week
Oral: swallowing the tablet
Mifepristone as its name
Easy: once a week and reminder via the app
No 'normal hormones' from the pill or other contraceptives
And More?
Almost anyone who menstruates (18-35 years) can participate in the study.
Mifepristone 50 mg once a week is expected to be a safe and effective contraceptive, with few side effects.
It is expected that monthly blood loss will decrease significantly when using this contraceptive and may possibly stop completely.